粒子増強比濁免疫測定法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Particle-Enhanced Turbidimetric Immunoassay Market Insights and Forecast to 2028

• レポートコード：QY2203B14223
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の粒子増強比濁免疫測定法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に粒子増強比濁免疫測定法の世界市場のxxx％を占める「キット・試薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の粒子増強比濁免疫測定法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの粒子増強比濁免疫測定法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの粒子増強比濁免疫測定法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

粒子増強比濁免疫測定法のグローバル主要メーカーには、Gentian Diagnostics、Thermo-Fisher Scientific、Buehlmann、Biotec、Abbott Laboratories、Roche、Siemens、Danaher Corporation、Diasorin SPA、Sysmex Corporation、Biomerieux、QIAGEN、Agilent Technologiesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

粒子増強比濁免疫測定法市場は、種類と用途によって区分されます。世界の粒子増強比濁免疫測定法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
キット・試薬、サービス

【用途別セグメント】
病院、学術・研究機関、製薬・バイオテクノロジー企業、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 粒子増強比濁免疫測定法製品概要
- 種類別市場（キット・試薬、サービス）
- 用途別市場（病院、学術・研究機関、製薬・バイオテクノロジー企業、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の粒子増強比濁免疫測定法販売量予測2017-2028
- 世界の粒子増強比濁免疫測定法売上予測2017-2028
- 粒子増強比濁免疫測定法の地域別販売量
- 粒子増強比濁免疫測定法の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別粒子増強比濁免疫測定法販売量
- 主要メーカー別粒子増強比濁免疫測定法売上
- 主要メーカー別粒子増強比濁免疫測定法価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（キット・試薬、サービス）
- 粒子増強比濁免疫測定法の種類別販売量
- 粒子増強比濁免疫測定法の種類別売上
- 粒子増強比濁免疫測定法の種類別価格
・用途別市場規模（病院、学術・研究機関、製薬・バイオテクノロジー企業、その他）
- 粒子増強比濁免疫測定法の用途別販売量
- 粒子増強比濁免疫測定法の用途別売上
- 粒子増強比濁免疫測定法の用途別価格
・北米市場
- 北米の粒子増強比濁免疫測定法市場規模（種類別、用途別）
- 主要国別の粒子増強比濁免疫測定法市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの粒子増強比濁免疫測定法市場規模（種類別、用途別）
- 主要国別の粒子増強比濁免疫測定法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の粒子増強比濁免疫測定法市場規模（種類別、用途別）
- 主要国別の粒子増強比濁免疫測定法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の粒子増強比濁免疫測定法市場規模（種類別、用途別）
- 主要国別の粒子増強比濁免疫測定法市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの粒子増強比濁免疫測定法市場規模（種類別、用途別）
- 主要国別の粒子増強比濁免疫測定法市場規模（トルコ、サウジアラビア）
・企業情報
Gentian Diagnostics、Thermo-Fisher Scientific、Buehlmann、Biotec、Abbott Laboratories、Roche、Siemens、Danaher Corporation、Diasorin SPA、Sysmex Corporation、Biomerieux、QIAGEN、Agilent Technologies
・産業チェーン及び販売チャネル分析
- 粒子増強比濁免疫測定法の産業チェーン分析
- 粒子増強比濁免疫測定法の原材料
- 粒子増強比濁免疫測定法の生産プロセス
- 粒子増強比濁免疫測定法の販売及びマーケティング
- 粒子増強比濁免疫測定法の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 粒子増強比濁免疫測定法の産業動向
- 粒子増強比濁免疫測定法のマーケットドライバー
- 粒子増強比濁免疫測定法の課題
- 粒子増強比濁免疫測定法の阻害要因
・主な調査結果

Particle-Enhanced Turbidimetric Immunoassays or PETIA is a biochemical process which uses optical change i.e. change in opaqueness caused by the agglutination of immunoparticles in the sample. These immunopartilcles are nothing but nanoparticles coated with antibodies. Their reaction with taken sample makes the mixture cloudy. A monochromatic light is then passed through the mixture to determine the opaqueness of turbidity of the mixture. Based on the absorption of light and pre-determined calibrations as per known and standardized concentrations, quantitative measurements of body fluid components like proteins, pathogens, serums, urine, plasma, etc can then be taken.
Market Analysis and Insights: Global Particle-Enhanced Turbidimetric Immunoassay Market
The global Particle-Enhanced Turbidimetric Immunoassay market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Kits or Reagents accounting for % of the Particle-Enhanced Turbidimetric Immunoassay global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Particle-Enhanced Turbidimetric Immunoassay market size is valued at US$ million in 2021, while the North America and Europe Particle-Enhanced Turbidimetric Immunoassay are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Particle-Enhanced Turbidimetric Immunoassay landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Particle-Enhanced Turbidimetric Immunoassay market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Particle-Enhanced Turbidimetric Immunoassay market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Particle-Enhanced Turbidimetric Immunoassay market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Particle-Enhanced Turbidimetric Immunoassay market.
Global Particle-Enhanced Turbidimetric Immunoassay Scope and Market Size
Particle-Enhanced Turbidimetric Immunoassay market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Particle-Enhanced Turbidimetric Immunoassay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Kits or Reagents
Service
Segment by Application
Hospitals
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Others
By Company
Gentian Diagnostics
Thermo-Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Kits or Reagents
1.2.3 Service
1.3 Market by Application
1.3.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Academic and Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Perspective (2017-2028)
2.2 Particle-Enhanced Turbidimetric Immunoassay Growth Trends by Region
2.2.1 Particle-Enhanced Turbidimetric Immunoassay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Region (2017-2022)
2.2.3 Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Region (2023-2028)
2.3 Particle-Enhanced Turbidimetric Immunoassay Market Dynamics
2.3.1 Particle-Enhanced Turbidimetric Immunoassay Industry Trends
2.3.2 Particle-Enhanced Turbidimetric Immunoassay Market Drivers
2.3.3 Particle-Enhanced Turbidimetric Immunoassay Market Challenges
2.3.4 Particle-Enhanced Turbidimetric Immunoassay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Revenue
3.1.1 Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Revenue (2017-2022)
3.1.2 Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Players (2017-2022)
3.2 Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Particle-Enhanced Turbidimetric Immunoassay Revenue
3.4 Global Particle-Enhanced Turbidimetric Immunoassay Market Concentration Ratio
3.4.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Particle-Enhanced Turbidimetric Immunoassay Revenue in 2021
3.5 Particle-Enhanced Turbidimetric Immunoassay Key Players Head office and Area Served
3.6 Key Players Particle-Enhanced Turbidimetric Immunoassay Product Solution and Service
3.7 Date of Enter into Particle-Enhanced Turbidimetric Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Particle-Enhanced Turbidimetric Immunoassay Breakdown Data by Type
4.1 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Type (2017-2022)
4.2 Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Type (2023-2028)
5 Particle-Enhanced Turbidimetric Immunoassay Breakdown Data by Application
5.1 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Application (2017-2022)
5.2 Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size (2017-2028)
6.2 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type
6.2.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022)
6.2.2 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028)
6.2.3 North America Particle-Enhanced Turbidimetric Immunoassay Market Share by Type (2017-2028)
6.3 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application
6.3.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022)
6.3.2 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028)
6.3.3 North America Particle-Enhanced Turbidimetric Immunoassay Market Share by Application (2017-2028)
6.4 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country
6.4.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022)
6.4.2 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size (2017-2028)
7.2 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Type
7.2.1 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022)
7.2.2 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028)
7.2.3 Europe Particle-Enhanced Turbidimetric Immunoassay Market Share by Type (2017-2028)
7.3 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Application
7.3.1 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022)
7.3.2 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028)
7.3.3 Europe Particle-Enhanced Turbidimetric Immunoassay Market Share by Application (2017-2028)
7.4 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country
7.4.1 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022)
7.4.2 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size (2017-2028)
8.2 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Type
8.2.1 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Share by Type (2017-2028)
8.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Application
8.3.1 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Share by Application (2017-2028)
8.4 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region
8.4.1 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size (2017-2028)
9.2 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type
9.2.1 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022)
9.2.2 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028)
9.2.3 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Share by Type (2017-2028)
9.3 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application
9.3.1 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022)
9.3.2 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028)
9.3.3 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Share by Application (2017-2028)
9.4 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country
9.4.1 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022)
9.4.2 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size (2017-2028)
10.2 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Type
10.2.1 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Share by Type (2017-2028)
10.3 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Application
10.3.1 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Share by Application (2017-2028)
10.4 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country
10.4.1 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gentian Diagnostics
11.1.1 Gentian Diagnostics Company Details
11.1.2 Gentian Diagnostics Business Overview
11.1.3 Gentian Diagnostics Particle-Enhanced Turbidimetric Immunoassay Introduction
11.1.4 Gentian Diagnostics Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.1.5 Gentian Diagnostics Recent Developments
11.2 Thermo-Fisher Scientific
11.2.1 Thermo-Fisher Scientific Company Details
11.2.2 Thermo-Fisher Scientific Business Overview
11.2.3 Thermo-Fisher Scientific Particle-Enhanced Turbidimetric Immunoassay Introduction
11.2.4 Thermo-Fisher Scientific Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.2.5 Thermo-Fisher Scientific Recent Developments
11.3 Buehlmann
11.3.1 Buehlmann Company Details
11.3.2 Buehlmann Business Overview
11.3.3 Buehlmann Particle-Enhanced Turbidimetric Immunoassay Introduction
11.3.4 Buehlmann Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.3.5 Buehlmann Recent Developments
11.4 Biotec
11.4.1 Biotec Company Details
11.4.2 Biotec Business Overview
11.4.3 Biotec Particle-Enhanced Turbidimetric Immunoassay Introduction
11.4.4 Biotec Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.4.5 Biotec Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Particle-Enhanced Turbidimetric Immunoassay Introduction
11.5.4 Abbott Laboratories Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.5.5 Abbott Laboratories Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Particle-Enhanced Turbidimetric Immunoassay Introduction
11.6.4 Roche Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.6.5 Roche Recent Developments
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Particle-Enhanced Turbidimetric Immunoassay Introduction
11.7.4 Siemens Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.7.5 Siemens Recent Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Particle-Enhanced Turbidimetric Immunoassay Introduction
11.8.4 Danaher Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.8.5 Danaher Corporation Recent Developments
11.9 Diasorin SPA
11.9.1 Diasorin SPA Company Details
11.9.2 Diasorin SPA Business Overview
11.9.3 Diasorin SPA Particle-Enhanced Turbidimetric Immunoassay Introduction
11.9.4 Diasorin SPA Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.9.5 Diasorin SPA Recent Developments
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Details
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation Particle-Enhanced Turbidimetric Immunoassay Introduction
11.10.4 Sysmex Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.10.5 Sysmex Corporation Recent Developments
11.11 Biomerieux
11.11.1 Biomerieux Company Details
11.11.2 Biomerieux Business Overview
11.11.3 Biomerieux Particle-Enhanced Turbidimetric Immunoassay Introduction
11.11.4 Biomerieux Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.11.5 Biomerieux Recent Developments
11.12 QIAGEN
11.12.1 QIAGEN Company Details
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Particle-Enhanced Turbidimetric Immunoassay Introduction
11.12.4 QIAGEN Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.12.5 QIAGEN Recent Developments
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Details
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Particle-Enhanced Turbidimetric Immunoassay Introduction
11.13.4 Agilent Technologies Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
11.13.5 Agilent Technologies Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Kits or Reagents
Table 3. Key Players of Service
Table 4. Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Region (2017-2022)
Table 8. Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Region (2023-2028)
Table 10. Particle-Enhanced Turbidimetric Immunoassay Market Trends
Table 11. Particle-Enhanced Turbidimetric Immunoassay Market Drivers
Table 12. Particle-Enhanced Turbidimetric Immunoassay Market Challenges
Table 13. Particle-Enhanced Turbidimetric Immunoassay Market Restraints
Table 14. Global Particle-Enhanced Turbidimetric Immunoassay Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Share by Players (2017-2022)
Table 16. Global Top Particle-Enhanced Turbidimetric Immunoassay by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Particle-Enhanced Turbidimetric Immunoassay as of 2021)
Table 17. Ranking of Global Top Particle-Enhanced Turbidimetric Immunoassay Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Particle-Enhanced Turbidimetric Immunoassay Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Particle-Enhanced Turbidimetric Immunoassay Product Solution and Service
Table 21. Date of Enter into Particle-Enhanced Turbidimetric Immunoassay Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Type (2017-2022)
Table 25. Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Type (2023-2028)
Table 27. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Share by Application (2017-2022)
Table 29. Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Share by Application (2023-2028)
Table 31. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2023-2028) & (US$ Million)
Table 61. Gentian Diagnostics Company Details
Table 62. Gentian Diagnostics Business Overview
Table 63. Gentian Diagnostics Particle-Enhanced Turbidimetric Immunoassay Product
Table 64. Gentian Diagnostics Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 65. Gentian Diagnostics Recent Developments
Table 66. Thermo-Fisher Scientific Company Details
Table 67. Thermo-Fisher Scientific Business Overview
Table 68. Thermo-Fisher Scientific Particle-Enhanced Turbidimetric Immunoassay Product
Table 69. Thermo-Fisher Scientific Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 70. Thermo-Fisher Scientific Recent Developments
Table 71. Buehlmann Company Details
Table 72. Buehlmann Business Overview
Table 73. Buehlmann Particle-Enhanced Turbidimetric Immunoassay Product
Table 74. Buehlmann Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 75. Buehlmann Recent Developments
Table 76. Biotec Company Details
Table 77. Biotec Business Overview
Table 78. Biotec Particle-Enhanced Turbidimetric Immunoassay Product
Table 79. Biotec Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 80. Biotec Recent Developments
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Particle-Enhanced Turbidimetric Immunoassay Product
Table 84. Abbott Laboratories Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 85. Abbott Laboratories Recent Developments
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Particle-Enhanced Turbidimetric Immunoassay Product
Table 89. Roche Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 90. Roche Recent Developments
Table 91. Siemens Company Details
Table 92. Siemens Business Overview
Table 93. Siemens Particle-Enhanced Turbidimetric Immunoassay Product
Table 94. Siemens Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 95. Siemens Recent Developments
Table 96. Danaher Corporation Company Details
Table 97. Danaher Corporation Business Overview
Table 98. Danaher Corporation Particle-Enhanced Turbidimetric Immunoassay Product
Table 99. Danaher Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 100. Danaher Corporation Recent Developments
Table 101. Diasorin SPA Company Details
Table 102. Diasorin SPA Business Overview
Table 103. Diasorin SPA Particle-Enhanced Turbidimetric Immunoassay Product
Table 104. Diasorin SPA Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 105. Diasorin SPA Recent Developments
Table 106. Sysmex Corporation Company Details
Table 107. Sysmex Corporation Business Overview
Table 108. Sysmex Corporation Particle-Enhanced Turbidimetric Immunoassay Product
Table 109. Sysmex Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 110. Sysmex Corporation Recent Developments
Table 111. Biomerieux Company Details
Table 112. Biomerieux Business Overview
Table 113. Biomerieux Particle-Enhanced Turbidimetric Immunoassay Product
Table 114. Biomerieux Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 115. Biomerieux Recent Developments
Table 116. QIAGEN Company Details
Table 117. QIAGEN Business Overview
Table 118. QIAGEN Particle-Enhanced Turbidimetric Immunoassay Product
Table 119. QIAGEN Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 120. QIAGEN Recent Developments
Table 121. Agilent Technologies Company Details
Table 122. Agilent Technologies Business Overview
Table 123. Agilent Technologies Particle-Enhanced Turbidimetric Immunoassay Product
Table 124. Agilent Technologies Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022) & (US$ Million)
Table 125. Agilent Technologies Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Type: 2021 VS 2028
Figure 2. Kits or Reagents Features
Figure 3. Service Features
Figure 4. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Academic and Research Institutions Case Studies
Figure 7. Pharmaceutical and Biotechnology Companies Case Studies
Figure 8. Others Case Studies
Figure 9. Particle-Enhanced Turbidimetric Immunoassay Report Years Considered
Figure 10. Global Particle-Enhanced Turbidimetric Immunoassay Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Particle-Enhanced Turbidimetric Immunoassay Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Region: 2021 VS 2028
Figure 13. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Players in 2021
Figure 14. Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Particle-Enhanced Turbidimetric Immunoassay as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Particle-Enhanced Turbidimetric Immunoassay Revenue in 2021
Figure 16. North America Particle-Enhanced Turbidimetric Immunoassay Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Type (2017-2028)
Figure 18. North America Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Application (2017-2028)
Figure 19. North America Particle-Enhanced Turbidimetric Immunoassay Market Size Share by Country (2017-2028)
Figure 20. United States Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Type (2017-2028)
Figure 24. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Application (2017-2028)
Figure 25. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size Share by Country (2017-2028)
Figure 26. Germany Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size Share by Region (2017-2028)
Figure 36. China Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size Share by Country (2017-2028)
Figure 46. Mexico Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Market Size Share by Country (2017-2028)
Figure 52. Turkey Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Gentian Diagnostics Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 56. Thermo-Fisher Scientific Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 57. Buehlmann Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 58. Biotec Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 59. Abbott Laboratories Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 61. Siemens Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 62. Danaher Corporation Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 63. Diasorin SPA Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 64. Sysmex Corporation Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 65. Biomerieux Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 66. QIAGEN Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 67. Agilent Technologies Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

リファービッシュドPCのグローバル市場インサイト・予測（～2028年）

Global Refurbished PC Market Insights and Forecast to 2028
QY2203B07041 2022年3月 90Pages
新型コロナウイルス感染症のパンデミックにより、世界のリファービッシュドPCの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリファービッシ...

アクティブエアサンプリングデバイスのグローバル市場インサイト・予測（～2028年）

Global Active Air Sampling Devices Market Insights, Forecast to 2028
QY2203B01323 2022年3月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界のアクティブエアサンプリングデバイスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にア...

ヨウ素-125のグローバル市場インサイト・予測（～2028年）

Global Iodine-125 Market Insights and Forecast to 2028
QY2203B06788 2022年3月 74Pages
新型コロナウイルス感染症のパンデミックにより、世界のヨウ素-125の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヨウ素-125の世界市...

ペプチド治療薬のグローバル市場インサイト・予測（～2028年）

Global Peptide Therapeutics Market Insights and Forecast to 2028
QY2203B05999 2022年3月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界のペプチド治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペプチド治療薬の世界市...

デオキシコール酸ナトリウムのグローバル市場インサイト・予測（～2028年）

Global Sodium Deoxycholate Market Insights, Forecast to 2028
QY2203B04182 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のデオキシコール酸ナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にデオキシコ...

グルタミルアミノペプチダーゼのグローバル市場インサイト・予測（～2028年）

Global Glutamyl Aminopeptidase Market Insights and Forecast to 2028
QY2203B02638 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のグルタミルアミノペプチダーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルタミ...

ライブVRのグローバル市場インサイト・予測（～2028年）

Global Live VR Market Insights, Forecast to 2028
QY2203B06806 2022年3月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界のライブVRの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にライブVRの世界市場のxx...

カスパーゼ8のグローバル市場インサイト・予測（～2028年）

Global Caspase 8 Market Insights and Forecast to 2028
QY2203B02252 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のカスパーゼ8の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカスパーゼ8の世界市場の...

スマートインドアガーデニングシステムのグローバル市場インサイト・予測（～2028年）

Global Smart Indoor Gardening System Market Insights and Forecast to 2028
QY2203B03598 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界のスマートインドアガーデニングシステムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021...

マイクロアルブミン測定器のグローバル市場インサイト・予測（～2028年）

Global Microalbumin Test Market Insights and Forecast to 2028
QY2203B06344 2022年3月 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のマイクロアルブミン測定器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にマイクロアル...

プロテインアッセイキットのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Protein Assay Kits Market Due to the COVID-19 pandemic, the global Protein Assay Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering…
リファービッシュドPCのグローバル市場インサイト・予測（～2028年） Refurbishment is the distribution of products (generally electronics) that have been previously returned to a manufacturer or vendor for various reasons, not sold in the market or new launch of a product. Refurbished products are normally tested for functionality and defects before they are sold to …
アデノウイルスELISAキットのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Adenovirus ELISA Kits Market Due to the COVID-19 pandemic, the global Adenovirus ELISA Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully consi…
製薬用冷蔵倉庫のグローバル市場インサイト・予測（～2028年） The quality of a pharmaceutical product is defined as one that is pure, correctly identified, effective and safe to use. Customers and patients have an ethical (and legal) right to expect quality pharmaceutical products. The warehouse plays a pivotal role in manufacturing quality products, as it is …
核酸マルチプレックスアッセイのグローバル市場インサイト・予測（～2028年） Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff Market Analysis and Insights: Global Nucleic Acid Multiplex Assays Market The global Nucleic…